Visual impairment as the initial presentation in multiple myeloma: a case report and literature review.

IF 1.5 4区 医学 Q4 ONCOLOGY Translational cancer research Pub Date : 2024-09-30 Epub Date: 2024-09-18 DOI:10.21037/tcr-24-511
Zhijian Xu, Song Yang, Lina Zhu, Xing Wan, Hu Xu, Huahui Chen, Lude Wang, Minfeng Tong, Qi Tu
{"title":"Visual impairment as the initial presentation in multiple myeloma: a case report and literature review.","authors":"Zhijian Xu, Song Yang, Lina Zhu, Xing Wan, Hu Xu, Huahui Chen, Lude Wang, Minfeng Tong, Qi Tu","doi":"10.21037/tcr-24-511","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Multiple myeloma (MM) is a type of blood cancer, which rarely infiltrates the central nervous system (CNS) and lacks specific neurological symptoms. The prognosis is often poor, as the disease progresses rapidly. Herein, we present a rare case of MM with CNS involvement.</p><p><strong>Case description: </strong>A 53-year-old man was admitted to the Neurosurgery Department, Jinhua Hospital Affiliated to Zhejiang University with initial symptoms of \"blurred vision for 3 months accompanied by numbness on the right side of the face for 7 days\". Enhanced cranial magnetic resonance imaging revealed a tumor deep in the right temporal bone. During exploratory surgery, the \"fleshy\" mass was completely removed. Postoperative pathology confirmed a diagnosis of \"plasmacytoma with intermediate features\". The patient received multiple systematic chemotherapy treatments after surgery in the department of hematology of Jinhua Hospital Affiliated to Zhejiang University. During a 10-month follow-up period, the patient's neurological symptoms improved, and his general condition was considered good.</p><p><strong>Conclusions: </strong>This report summarizes the clinical features, diagnosis, treatment, and prognosis of a patient with MM involving the CNS and examines the relevant literature. This case may serve as a reference for future clinical treatment and diagnosis. Further research on the pathophysiology of such cases is warranted.</p>","PeriodicalId":23216,"journal":{"name":"Translational cancer research","volume":"13 9","pages":"5149-5156"},"PeriodicalIF":1.5000,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11483438/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational cancer research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/tcr-24-511","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/18 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Multiple myeloma (MM) is a type of blood cancer, which rarely infiltrates the central nervous system (CNS) and lacks specific neurological symptoms. The prognosis is often poor, as the disease progresses rapidly. Herein, we present a rare case of MM with CNS involvement.

Case description: A 53-year-old man was admitted to the Neurosurgery Department, Jinhua Hospital Affiliated to Zhejiang University with initial symptoms of "blurred vision for 3 months accompanied by numbness on the right side of the face for 7 days". Enhanced cranial magnetic resonance imaging revealed a tumor deep in the right temporal bone. During exploratory surgery, the "fleshy" mass was completely removed. Postoperative pathology confirmed a diagnosis of "plasmacytoma with intermediate features". The patient received multiple systematic chemotherapy treatments after surgery in the department of hematology of Jinhua Hospital Affiliated to Zhejiang University. During a 10-month follow-up period, the patient's neurological symptoms improved, and his general condition was considered good.

Conclusions: This report summarizes the clinical features, diagnosis, treatment, and prognosis of a patient with MM involving the CNS and examines the relevant literature. This case may serve as a reference for future clinical treatment and diagnosis. Further research on the pathophysiology of such cases is warranted.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
多发性骨髓瘤初期表现为视力障碍:病例报告和文献综述。
背景:多发性骨髓瘤(MM)是一种血癌,很少浸润中枢神经系统(CNS),也没有特殊的神经症状。由于病情进展迅速,预后通常较差。在此,我们介绍一例罕见的中枢神经系统受累的 MM 病例:一名 53 岁的男性因 "视力模糊 3 个月,伴右侧面部麻木 7 天 "的最初症状入住浙江大学附属金华医院神经外科。增强头颅磁共振成像显示右颞骨深部有一肿瘤。在探查手术中,"肉质 "肿块被完全切除。术后病理确诊为 "具有中间特征的浆细胞瘤"。术后,患者在浙江大学附属金华医院血液科接受了多次系统化疗。在 10 个月的随访期间,患者的神经系统症状有所改善,一般情况良好:本报告总结了一名累及中枢神经系统的 MM 患者的临床特征、诊断、治疗和预后,并对相关文献进行了研究。本病例可为今后的临床治疗和诊断提供参考。我们有必要对此类病例的病理生理学进行进一步研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.10
自引率
0.00%
发文量
252
期刊介绍: Translational Cancer Research (Transl Cancer Res TCR; Print ISSN: 2218-676X; Online ISSN 2219-6803; http://tcr.amegroups.com/) is an Open Access, peer-reviewed journal, indexed in Science Citation Index Expanded (SCIE). TCR publishes laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer; results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of cancer patients. The focus of TCR is original, peer-reviewed, science-based research that successfully advances clinical medicine toward the goal of improving patients'' quality of life. The editors and an international advisory group of scientists and clinician-scientists as well as other experts will hold TCR articles to the high-quality standards. We accept Original Articles as well as Review Articles, Editorials and Brief Articles.
期刊最新文献
Construction and validation of prognostic model for colorectal mucinous adenocarcinoma patients and identification of a new prognosis related gene FAM174B. Erratum: Identification of a ferroptosis-related gene signature for the prognosis of pediatric neuroblastoma. Establishment and validation of a prediction model for gastric cancer with perineural invasion based on preoperative inflammatory markers. Establishment and verification of a prognostic immune cell signature-based model for breast cancer overall survival. Exosomal AHSG in ovarian cancer ascites inhibits malignant progression of ovarian cancer by p53/FAK/Src signaling.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1